<DOC>
	<DOCNO>NCT02798159</DOCNO>
	<brief_summary>The purpose study identify optimal dose ( ) TD0025 treatment erectile dysfunction ( phase II ) investigate treatment erectile dysfunction optimal dose TD0025 take need one month non-inferior Sildenafil Citrate take need one month ( phase III )</brief_summary>
	<brief_title>Safety Efficacy TD0025 ( Rocket1h ) Treatment Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Main History Erectile Dysfunction ( ED ) least 1 month duration . Anticipate adult female sexual partner study . Agree use treatment ED participate recording response questionnaires instrument use study . Sign inform consent form Main ED cause primary sexual disorder , history radical prostatectomy pelvic surgery subsequent failure achieve erection , history penile implant clinically significant penile deformity ED cause untreated inadequately treated endocrine disease Current treatment doxazocin , nitrate , cancer chemotherapy , antiandrogens Severe renal hepatic impairment , history malignant hypertension Presence history specific heart condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Sexual Dysfunction</keyword>
	<keyword>Physiological Sexual Dysfunctions</keyword>
	<keyword>Psychological Sexual Gender Disorders</keyword>
	<keyword>Sildenafil</keyword>
</DOC>